Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Osteoarthritis and Bone Disorders

Can Lubricating Joints Prevent Osteoarthritis?

Deepak Rao MD, PhD  |  June 13, 2013

 Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)

Th17 May Contribute to Bone Destruction by Modifying Osteoclasts

Lara C. Pullen, PhD  |  June 3, 2013

New research describes the role of RANKL-expressing Th17 cells in inflammatory bone destruction. (posted June 3, 2013)

ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies

Thomas R. Collins  |  April 1, 2013

Studies look at how the balance between osteoclast-mediated bone resorption and osteoblast mediated bone formation is undermined in people with arthritic conditions

ACR/ARHP Annual Meeting 2012: Will Novel Strategies Lead to Breakthroughs in Treating Osteoarthritis?

Susan Bernstein  |  February 1, 2013

 

ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis

Susan Bernstein  |  February 1, 2013

Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery

New Hydrogel May Offer Promising Osteoarthritis Treatment

Kurt Ullman  |  January 16, 2013

A new hydrogel that can be stretched and is self-healing might become an effective ligament repair option in osteoarthritis (OA).

ACR/ARHP Annual Meeting 2012: New Treatments and Strategies Emerge for Osteoporosis

Thomas R. Collins  |  January 1, 2013

Rheumatology experts urge caution in using bisphosphonates to prevent bone loss

ARHP News: Occupational and Hand Therapy in Treatment of Osteoarthritis

Carole V. Dodge, OT, CHT  |  November 2, 2012

Osteoarthritis (OA) of the hand is one of the more frequent diagnoses seen in a hand clinic, though early referral to an occupational therapist can improve hand function in patients with OA

Coding Corner Question: November

Staff  |  November 1, 2012

Test your knowledge of the level of medical decision making (MDM) for an evaluation and management (E/M) office visit of a patient whose rheumatoid arthritis is worse on chronic medicine, whose osteoporosis is stable on chronic medicine, and who presents with a new problem of elevated blood pressure (BP)

What Rheumatologists Should Look for in Diagnosing SAPHO Syndrome

Richard Brasington, MD  |  November 1, 2012

SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis, and osteitis) is an obscure condition that can vex patients and clinicians

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences